Siyanda Mazaleni | Epigenetics | Women Researcher Award

Published on by Global Academic Awards

Ms. Siyanda Mazaleni | Epigenetics | Women Researcher Award

Ms. Siyanda Mazaleni | University of KwaZulu-Natal | South Africa

Ms. Siyanda Mazaleni is an emerging medical bioscience researcher from South Africa, currently pursuing a PhD in Health Sciences (Medical Biochemistry) at the University of KwaZulu-Natal, focusing on the genetic and epigenetic regulation of RAS components in children with ureteropelvic junction obstruction and posterior urethral valves. She holds a BSc in Medical Biosciences and a BSc (Hons) with majors in applied immunology, anatomical science, and advanced studies in reproduction and health from the University of the Western Cape, as well as an MSc in Medical Science (Medical Biochemistry) from UKZN, where her research investigated DNA hypomethylation induced by Deoxynivalenol in HepG2 cells. Siyanda has co-authored publications including a systematic review on epigenetics, COVID-19, and Vitamin D, and original research in Food and Chemical Toxicology. She has extensive academic experience as a demonstrator, student assistant, and facilitator, demonstrating strong mentorship and teaching skills. Her work reflects a commitment to advancing knowledge in medical biochemistry and promoting scientific research in South Africa.

Publication Profile

Scopus

Google scholar

Education

Ms. Siyanda Mazaleni has pursued a distinguished academic path in medical biosciences and biochemistry. She completed her BSc in Medical Biosciences at the University of the Western Cape, covering core subjects such as anatomy and physiology, medical microbiology, statistics, life sciences, biotechnology, chemistry, and computer literacy. Building on this foundation, she earned a BSc (Hons) in Medical Biosciences from the same university, specializing in applied immunology, anatomical science, advanced reproductive health studies, nutritional bioscience, and laboratory techniques, with a research project focused on cardiovascular disease. Siyanda further advanced her expertise with an MSc in Medical Science (Medical Biochemistry) at the University of KwaZulu-Natal, conducting research on DNA hypomethylation induced by Deoxynivalenol through modulation of miR-29b expression in HepG2 cells. She is currently pursuing a PhD in Health Sciences (Medical Biochemistry) at UKZN, investigating the role of genetic and epigenetic changes in regulating RAS components in children with ureteropelvic junction obstruction and posterior urethral valves in KwaZulu-Natal, reflecting her commitment to advancing research in medical biochemistry.

Professional Experience

Ms. Siyanda Mazaleni has gained extensive experience in both academic and research settings at the University of KwaZulu-Natal. She has served as a demonstrator in Medical Biochemistry, where she assisted in teaching, mentoring students, and supporting laboratory-based practical sessions, contributing to the development of future healthcare professionals. In addition, she worked as a student assistant at the UKZN Howard College Libraries, gaining valuable skills in information management, research support, and academic resource facilitation. Her commitment to education and student development is further demonstrated through her role as a facilitator at the College of Health Sciences, where she guided and supported students in understanding complex scientific concepts and laboratory techniques. These roles have not only strengthened her technical and organizational skills but also highlight her dedication to mentorship, academic excellence, and fostering a collaborative and supportive learning environment within the university.

Research Focus

Ms. Siyanda Mazaleni’s research primarily focuses on molecular and medical biochemistry, with a strong emphasis on epigenetics, gene regulation, and the molecular mechanisms underlying human health and disease. Her work explores how genetic and epigenetic modifications influence cellular processes, as demonstrated in her PhD project investigating the regulation of RAS components in children with ureteropelvic junction obstruction and posterior urethral valves. She has also studied the effects of environmental toxins, such as Deoxynivalenol, on global DNA methylation and the modulation of microRNA expression in liver cells, highlighting her interest in the intersection of toxicology and epigenetic regulation. Additionally, her systematic review on the links between epigenetics, COVID-19, and vitamin D reflects a broader focus on how molecular mechanisms impact human immunity and health outcomes. Overall, Siyanda’s research integrates molecular biology, epigenetics, and health sciences, contributing valuable insights into disease mechanisms, nutritional influences, and potential therapeutic targets, positioning her as an innovative and impactful early-career researcher.

Publication Top Notes

A review: Highlighting the links between epigenetics, COVID-19 infection, and vitamin D
Years: 2022
Citations: 17

Titles: Deoxynivalenol induces global DNA hypomethylation by modulating the expression of miR-29b and DNA methylation regulators in HepG2 cells
Years: 2025

Conclusion

Ms. Siyanda Mazaleni is a highly promising early-career researcher with a strong academic record, innovative research contributions, and active mentorship experience. Her work aligns with the objectives of the Research for Women Researcher Award, making her a suitable and deserving candidate for recognition.

Peng Zhang | Biological Science | Best Researcher Award

Published on by Global Academic Awards

Dr. Peng Zhang | Biological Science | Best Researcher Award

Assistant Professor, Tianjin University of Technology, China

Dr. Peng Zhang is an Assistant Professor at the Life and Health Intelligent Research Institute, Tianjin University of Technology. With a strong focus on understanding gut microbiota and its impact on health, Dr. Zhang combines expertise in natural product research with advanced omics technologies. His work explores innovative ways to improve bioavailability and efficacy of therapeutic agents. 🌟

Publication Profile

Strengths for the Award:

  1. Innovative Research Focus: Peng Zhang’s work on natural products, drug delivery systems, and the role of gut microbiota in health demonstrates a high level of innovation and relevance in the field of life and health sciences.
  2. Significant Publications: Zhang has a strong publication record in reputable journals, including Journal of Functional Foods, Journal of Agricultural and Food Chemistry, and The ISME Journal. His research on gut microbiota and its impact on health conditions showcases his expertise and contributions to the field.
  3. Active Projects: Leading national projects funded by the National Natural Science Foundation of China, Zhang’s research includes high-impact topics like antibiotic resistance and its effects on gut microbiota. This aligns with current global health challenges.
  4. Diverse Experience: Zhang’s experience spans from studying the effects of natural products on obesity to the development of nanotechnology-based drug delivery systems, indicating a broad and applied approach to research.

Areas for Improvement:

  1. Broader Impact and Outreach: While Zhang’s research is impactful, expanding efforts to disseminate findings to a wider audience, including the general public and policymakers, could enhance the societal impact of his work.
  2. Collaborations and Networking: Increasing collaborations with international researchers and institutions could further strengthen his research’s global relevance and visibility.
  3. Grant and Project Diversification: Although Zhang has led and participated in significant projects, diversifying funding sources and project scopes might provide additional opportunities for groundbreaking research.

Education

Dr. Zhang earned his PhD from Nankai University, Tianjin, China, in 2021, where he developed models to study the role of gut microbiota in health crises caused by antibiotics. Prior to this, he completed his graduate studies at Hainan University, Haikou, China, focusing on the effects of dietary compounds on obesity. 🎓

Experience

2022 – Present: Assistant Professor, Life and Health Intelligent Research Institute, Tianjin University of Technology, Tianjin, China. Research includes purifying natural products and developing nanotechnology-based drug delivery systems. 🔬2017 – 2021: PhD student, Nankai University, Tianjin, China. Developed models to study antibiotic exposure and drug-resistant bacteria. 🧪2015 – 2017: Graduate student, Hainan University, Haikou, China. Examined effects of Luo Han Guo on obesity. 🌿

Research Focus

Dr. Zhang’s research primarily investigates the role of natural products in alleviating inflammatory diseases and improving gut health. His projects include:

Purifying Natural Products: Studying polysaccharides and polyphenols from medicinal foods to understand their impact on inflammatory diseases and gut microbiota. 🌱Drug Delivery Systems: Developing nanotechnology-based encapsulation systems to enhance the bioavailability of active compounds. 🚀

Awards and Honours

Dr. Zhang’s contributions to the field are recognized through various awards and honors. Notable mentions include his significant contributions to understanding the interactions between gut microbiota and therapeutic agents. 🏅

Publications Top Note

Biological Science, Biological Research, Life Sciences

  1. Polysaccharides isolated from Hibiscus sabdariffa L. mitigate intestinal radiation injury, Journal of Functional Foods, 2024.
  2. Polysaccharide Isolated from Agaricus blazei Murill Alleviates Intestinal Ischemia/Reperfusion Injury, Journal of Agricultural and Food Chemistry, 2024.
  3. The Gut Microbiota Contributes to Systemic Responses and Liver Injury in Gut-Derived Sepsis, Microorganisms, 2023.
  4. Porphyromonas gingivalis exacerbates alcoholic liver disease, Journal of Clinical Periodontology, 2023.
  5. Gut microbiota exaggerates triclosan-induced liver injury, Journal of Hazardous Materials, 2022.

 

Conclusion:

Peng Zhang is a highly qualified candidate for the Research for Best Researcher Award. His innovative research, strong publication record, and leadership in significant projects underscore his contributions to the field. Addressing areas for improvement, such as expanding outreach and fostering international collaborations, could further enhance his impact and recognition in the global research community.

 

Milad Mollaali | Epigeneics | Best Researcher Award

Published on by Global Academic Awards

Mr. Milad Mollaali | Epigeneics | Best Researcher Award

Milad Mollaali, University of Sistan and Baluchestan, Iran

Milad Mollaali is a dedicated researcher specializing in genetic epidemiology and molecular biology, focusing on cancer genetics and autoimmune diseases. His work spans several high-impact journals, contributing significantly to the understanding of genetic markers in disease susceptibility.

Profile

Orcid

Education 📚

Milad Mollaali holds a Ph.D. in Molecular Biology , where he specialized in genetic epidemiology and molecular genetics.

Experience 💼

Milad Mollaali has extensive experience in genetic research, particularly in cancer genetics and autoimmune diseases. He has contributed to numerous studies exploring gene expressions and polymorphisms related to various cancers, enhancing the understanding of disease mechanisms.

Awards 🏆

Milad Mollaali has been recognized for his contributions to genetic epidemiology and cancer research, receiving awards for excellence in scientific research and publication.

Research focus

Milad Mollaali’s research primarily focuses on genetic aspects of various cancers prevalent in Iran, particularly oral squamous cell carcinoma (OSCC) and gastric cancer. He investigates gene expressions such as JAK2, STAT3, CTLA4, DRD1, NF-κB, TRAF1, and TRAF2, along with genetic polymorphisms like rs774034163. His studies contribute significantly to understanding the molecular mechanisms underlying cancer development and progression in Iranian populations. 🧬 His work aims to elucidate biomarkers and potential therapeutic targets, offering insights into personalized medicine approaches for cancer management in the region.

Publications Top Notes📄

Association of HLA‐DQ4/5 genotype polymorphisms with celiac disease in a group of children in Southwest Iran: A case‐control study

Reporting an Iranian Female Patient Suffering from Colorectal Cancer with a Missense Mutation in Exon 2 of MEN1 Gene: An Unusual Case

Evaluation of DRD1 Gene Expression Pattern and rs774034163 Genetic Polymorphism in Patients with Gastric Cancer: A Case-Control Study in Iran

Investigation of the NF-κB, TRAF1, and TRAF2 Relative Gene Expressions in a Population of Iranian Patients with Oral Squamous Cell Carcinoma: A Case-Control Study

Assessing the Relationship of C-FOS Gene Expression and rs997415225 Polymorphism with Gastric Cancer in the Iranian Population of Isfahan Province

Studying the Association of Gene Expressions and Gene Polymorphisms of MAPK14 rs28763973) and HTR2B rs550352538) with Gastric Cancer in Isfahan Province